RxDoctor Payments Data

David Smith

Hematology & Oncology · Vancouver, WANPI 1528061181

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $5,940 of the $5,940 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Verastem, Inc..

$5,940in general payments, 2019–2025

Across 1 payment — averaging $5940.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Verastem, Inc.$6K
$838,406in research payments, 2019–2025

Across 66 payments — averaging $12,703 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • E.r. Squibb & Sons, L.L.C.$301K
  • Amgen$212K
  • Merck$194K
  • Genentech, Inc.$121K
  • EMD Serono, Inc.$6K
  • AstraZeneca$3K
  • plus $1K from 1 others

What the payments were for

  • Consulting fees$5,940100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Verastem, Inc.1$5,940

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,940 in reported general payments places this provider in the 70th percentile of 349 hematology & oncology providers in Washington.

See all hematology & oncology providers in Washington

Other hematology & oncology in Vancouver

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →